Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration

Experimental Eye Research

Volumn 120, Issue , 2014, Pages 175-185

  Lax, Pedro ^a   Esquiva, Gema ^a   Altavilla, Cesare ^a   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Apoptosis; Confocal microscopy; Electroretinography; Immunohistochemistry; Neurodegeneration; P23H; Retinitis pigmentosa

Indexed keywords

APOPTOSIS; CONFOCAL MICROSCOPY; ELECTRORETINOGRAPHY; IMMUNOHISTOCHEMISTRY; NEURODEGENERATION; P23H; RETINITIS PIGMENTOSA;

ANIMALS; BIOLOGICAL MARKERS; CANNABINOID RECEPTOR AGONISTS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRONABINOL; ELECTRORETINOGRAPHY; EYE PROTEINS; MICROSCOPY, CONFOCAL; NEUROPROTECTIVE AGENTS; NIGHT VISION; PHOTIC STIMULATION; PRESYNAPTIC TERMINALS; RATS; RATS, TRANSGENIC; RETINA; RETINAL BIPOLAR CELLS; RETINITIS PIGMENTOSA;

DEXANABINOL;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; B WAVE; CONTROLLED STUDY; CYTOARCHITECTURE; DARK ADAPTATION; DENDRITE; DRUG EFFECT; ELECTRORETINOGRAM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; NERVE ENDING; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA ROD OUTER SEGMENT; RETINITIS PIGMENTOSA; SPRAGUE DAWLEY RAT; WILD TYPE RAT;

EID: 84894088824     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.01.019     Document Type: Article

References (81)

1. Ahuja P., Caffe A.R., Ahuja S., Ekstrom P., van Veen T. Decreased glutathione transferase levels in rd1/rd1 mouse retina: replenishment protects photoreceptors in retinal explants. Neuroscience 2005, 131:935-943.
2. Berson E.L., Rosner B., Sandberg M.A., Dryja T.P. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch. Ophthalmol. 1991, 109:92-101.
3. Berson E.L., Rosner B., Sandberg M.A., Hayes K.C., Nicholson B.W., Weigel-DiFranco C., Willett W. Arandomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch. Ophthalmol. 1993, 111:761-772.
4. Bouskila J., Burke M.W., Zabouri N., Casanova C., Ptito M., Bouchard J.F. Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys. Neuroscience 2012, 202:117-130.
5. Bouskila J., Javadi P., Casanova C., Ptito M., Bouchard J.F. Muller cells express the cannabinoid CB2 receptor in the vervet monkey retina. J.Comp. Neurol. 2013, 521:2399-2415.
6. Cayouette M., Behn D., Sendtner M., Lachapelle P., Gravel C. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J.Neurosci. 1998, 18:9282-9293.
7. Cayouette M., Smith S.B., Becerra S.P., Gravel C. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol. Dis. 1999, 6:523-532.
8. Cecyre B., Zabouri N., Huppe-Gourgues F., Casanova C., Bouchard J.F. Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice. Investig. Ophthalmol. Vis. Sci. 2013, 54:8079-8090.
9. Chong N.H., Alexander R.A., Waters L., Barnett K.C., Bird A.C., Luthert P.J. Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Investig. Ophthalmol. Vis. Sci. 1999, 40:1298-1305.
10. Crandall J., Matragoon S., Khalifa Y.M., Borlongan C., Tsai N.T., Caldwell R.B., Liou G.I. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Res. 2007, 39:69-75.
11. Cuenca N., Pinilla I., Sauve Y., Lu B., Wang S., Lund R.D. Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience 2004, 127:301-317.
12. Dagon Y., Avraham Y., Link G., Zolotarev O., Mechoulam R., Berry E.M. The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells. Neurobiol. Dis. 2007, 27:174-181.
13. Doonan F., Cotter T.G. Apoptosis: a potential therapeutic target for retinal degenerations. Curr. Neurovasc. Res. 2004, 1:41-53.
14. Dryja T.P., McEvoy J.A., McGee T.L., Berson E.L. Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa. Investig. Ophthalmol. Vis. Sci. 2000, 41:3124-3127.
15. Dryja T.P., McGee T.L., Reichel E., Hahn L.B., Cowley G.S., Yandell D.W., Sandberg M.A., Berson E.L. Apoint mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990, 343:364-366.
16. El-Remessy A.B., Khalil I.E., Matragoon S., Abou-Mohamed G., Tsai N.J., Roon P., Caldwell R.B., Caldwell R.W., Green K., Liou G.I. Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am. J. Pathol. 2003, 163:1997-2008.
17. Eljaschewitsch E., Witting A., Mawrin C., Lee T., Schmidt P.M., Wolf S., Hoertnagl H., Raine C.S., Schneider-Stock R., Nitsch R., Ullrich O. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006, 49:67-79.
18. Fan S.F., Yazulla S. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Vis. Neurosci. 2003, 20:177-188.
19. Fernandez-Bueno I., Fernandez-Sanchez L., Gayoso M.J., Garcia-Gutierrez M.T., Pastor J.C., Cuenca N. Time course modifications in organotypic culture of human neuroretina. Exp. Eye Res. 2012, 104:26-38.
20. Fernandez-Ruiz J., Garcia C., Sagredo O., Gomez-Ruiz M., de Lago E. The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin. Ther. Targets 2010, 14:387-404.
21. Fernandez-Ruiz J., Romero J., Velasco G., Tolon R.M., Ramos J.A., Guzman M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?. Trends Pharmacol. Sci. 2007, 28:39-45.
22. Fernandez-Sanchez L., Lax P., Esquiva G., Martin-Nieto J., Pinilla I., Cuenca N. Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. PLoS One 2012, 7:e43074.
23. Fernandez-Sanchez L., Lax P., Isiegas C., Ayuso E., Ruiz J.M., de la Villa P., Bosch F., de la Rosa E.J., Cuenca N. Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa. Hum. Gene Ther. 2012, 23:1290-1300.
24. Fernandez-Sanchez L., Lax P., Pinilla I., Martin-Nieto J., Cuenca N. Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. Investig. Ophthalmol. Vis. Sci. 2011, 52:4998-5008.
25. Garcia-Arencibia M., Gonzalez S., de Lago E., Ramos J.A., Mechoulam R., Fernandez-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 2007, 1134:162-170.
26. Garcia-Ayuso D., Ortin-Martinez A., Jimenez-Lopez M., Galindo-Romero C., Cuenca N., Pinilla I., Vidal-Sanz M., Agudo-Barriuso M., Villegas-Perez M.P. Changes in the photoreceptor mosaic of P23H-1 rats during retinal degeneration: implications for rod-cone dependent survival. Investig. Ophthalmol. Vis. Sci. 2013, 54:5888-5900.
27. Garcia-Ayuso D., Salinas-Navarro M., Agudo M., Cuenca N., Pinilla I., Vidal-Sanz M., Villegas-Perez M.P. Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina. Exp. Eye Res. 2010, 91:800-810.
28. Green E.S., Rendahl K.G., Zhou S., Ladner M., Coyne M., Srivastava R., Manning W.C., Flannery J.G. Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Mol. Ther. 2001, 3:507-515.
29. Hampson A.J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8268-8273.
30. Hampson A.J., Grimaldi M., Lolic M., Wink D., Rosenthal R., Axelrod J. Neuroprotective antioxidants from marijuana. Ann. N. Y. Acad. Sci. 2000, 899:274-282.
31. Hartong D.T., Berson E.L., Dryja T.P. Retinitis pigmentosa. Lancet 2006, 368:1795-1809.
32. Illing M.E., Rajan R.S., Bence N.F., Kopito R.R. Arhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J.Biol. Chem. 2002, 277:34150-34160.
33. Jones B.W., Marc R.E. Retinal remodeling during retinal degeneration. Exp. Eye Res. 2005, 81:123-137.
34. Kaushal S., Khorana H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994, 33:6121-6128.
35. Khaspekov L.G., Brenz Verca M.S., Frumkina L.E., Hermann H., Marsicano G., Lutz B. Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur. J. Neurosci. 2004, 19:1691-1698.
36. Kolomiets B., Dubus E., Simonutti M., Rosolen S., Sahel J.A., Picaud S. Late histological and functional changes in the P23H rat retina after photoreceptor loss. Neurobiol. Dis. 2010, 38:47-58.
37. Komeima K., Rogers B.S., Lu L., Campochiaro P.A. Antioxidants reduce cone cell death in a model of retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11300-11305.
38. Lalonde M.R., Jollimore C.A., Stevens K., Barnes S., Kelly M.E. Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells. Mol. Vis. 2006, 12:1160-1166.
39. Lax P., Otalora B.B., Esquiva G., Rol Mde L., Madrid J.A., Cuenca N. Circadian dysfunction in P23H rhodopsin transgenic rats: effects of exogenous melatonin. J.Pineal Res. 2011, 50:183-191.
40. Leker R.R., Gai N., Mechoulam R., Ovadia H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 2003, 34:2000-2006.
41. Leveillard T., Mohand-Said S., Lorentz O., Hicks D., Fintz A.C., Clerin E., Simonutti M., Forster V., Cavusoglu N., Chalmel F., Dolle P., Poch O., Lambrou G., Sahel J.A. Identification and characterization of rod-derived cone viability factor. Nat. Genet. 2004, 36:755-759.
42. Liang F.Q., Aleman T.S., Yang Zaixin, Cideciyan A.V., Jacobson S.G., Bennett J. Melatonin delays photoreceptor degeneration in the rds/rds mouse. Neuroreport 2001, 12:1011-1014.
43. Little P.J., Compton D.R., Mechoulam R., Martin B.R. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 1989, 32:661-666.
44. Lopez E.M., Tagliaferro P., Onaivi E.S., Lopez-Costa J.J. Distribution of CB2 cannabinoid receptor in adult rat retina. Synapse 2011, 65:388-392.
45. Machida S., Kondo M., Jamison J.A., Khan N.W., Kononen L.T., Sugawara T., Bush R.A., Sieving P.A. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Investig. Ophthalmol. Vis. Sci. 2000, 41:3200-3209.
46. Marc R.E., Jones B.W. Retinal remodeling in inherited photoreceptor degenerations. Mol. Neurobiol. 2003, 28:139-147.
47. Marc R.E., Jones B.W., Watt C.B., Strettoi E. Neural remodeling in retinal degeneration. Prog. Retin Eye Res. 2003, 22:607-655.
48. Marsicano G., Moosmann B., Hermann H., Lutz B., Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J.Neurochem. 2002, 80:448-456.
49. Martinez-Navarrete G., Seiler M.J., Aramant R.B., Fernandez-Sanchez L., Pinilla I., Cuenca N. Retinal degeneration in two lines of transgenic S334ter rats. Exp. Eye Res. 2011, 92:227-237.
50. McGee Sanftner L.H., Abel H., Hauswirth W.W., Flannery J.G. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol. Ther. 2001, 4:622-629.
51. Mechoulam R., Feigenbaum J.J., Lander N., Segal M., Jarbe T.U., Hiltunen A.J., Consroe P. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia 1988, 44:762-764.
52. Middleton T.P., Protti D.A. Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. Vis. Neurosci. 2011, 28:393-402.
53. Musarella M.A., Macdonald I.M. Current concepts in the treatment of retinitis pigmentosa. J.Ophthalmol. 2011, 2011:753547.
54. 2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211. Brain Res. 1993, 622:79-85.
55. Nucci C., Gasperi V., Tartaglione R., Cerulli A., Terrinoni A., Bari M., De Simone C., Agro A.F., Morrone L.A., Corasaniti M.T., Bagetta G., Maccarrone M. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Investig. Ophthalmol. Vis. Sci. 2007, 48:2997-3004.
56. Okoye G., Zimmer J., Sung J., Gehlbach P., Deering T., Nambu H., Hackett S., Melia M., Esumi N., Zack D.J., Campochiaro P.A. Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage. J.Neurosci. 2003, 23:4164-4172.
57. Opere C.A., Zheng W.D., Zhao M., Lee J.S., Kulkarni K.H., Ohia S.E. Inhibition of potassium- and ischemia-evoked [3H] D-aspartate release from isolated bovine retina by cannabinoids. Curr. Eye Res. 2006, 31:645-653.
58. Ottani A., Giuliani D. Hu 210: a potent tool for investigations of the cannabinoid system. CNS Drug. Rev. 2001, 7:131-145.
59. Pellegrini-Giampietro D.E., Mannaioni G., Bagetta G. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J. 2009, 276:2-12.
60. Pertwee R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 1999, 6:635-664.
61. Pertwee R.G. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos. Trans. R. Soc. Lond B Biol. Sci. 2012, 367:3353-3363.
62. Pinar-Sueiro S., Zorrilla Hurtado J.A., Veiga-Crespo P., Sharma S.C., Vecino E. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. Exp. Eye Res. 2013, 110:55-58.
63. Pinilla I., Cuenca N., Sauve Y., Wang S., Lund R.D. Preservation of outer retina and its synaptic connectivity following subretinal injections of human RPE cells in the Royal College of Surgeons rat. Exp. Eye Res. 2007, 85:381-392.
64. Pinilla I., Lund R.D., Sauve Y. Enhanced cone dysfunction in rats homozygous for the P23H rhodopsin mutation. Neurosci. Lett. 2005, 382:16-21.
65. Pope C., Mechoulam R., Parsons L. Endocannabinoid signaling in neurotoxicity and neuroprotection. Neurotoxicology 2010, 31:562-571.
66. Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J.Neurosci. 2005, 25:1904-1913.
67. Reme C.E., Grimm C., Hafezi F., Marti A., Wenzel A. Apoptotic cell death in retinal degenerations. Prog. Retin Eye Res. 1998, 17:443-464.
68. Ripps H. Cell death in retinitis pigmentosa: gap junctions and the 'bystander' effect. Exp. Eye Res. 2002, 74:327-336.
69. Rubio M., Villain H., Docagne F., Roussel B.D., Ramos J.A., Vivien D., Fernandez-Ruiz J., Ali C. Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults. PLoS One 2011, 6:e23690.
70. Shohami E., Novikov M., Mechoulam R. Anonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J.Neurotrauma 1993, 10:109-119.
71. Stieger K. tgAAG76, an adeno-associated virus delivered gene therapy for the potential treatment of vision loss caused by RPE65 gene abnormalities. Curr. Opin. Mol. Ther. 2010, 12:471-477.
72. Stone J., Maslim J., Valter-Kocsi K., Mervin K., Bowers F., Chu Y., Barnett N., Provis J., Lewis G., Fisher S.K., Bisti S., Gargini C., Cervetto L., Merin S., Peer J. Mechanisms of photoreceptor death and survival in mammalian retina. Prog. Retin Eye Res. 1999, 18:689-735.
73. Straiker A., Stella N., Piomelli D., Mackie K., Karten H.J., Maguire G. Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14565-14570.
74. Straiker A., Sullivan J.M. Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. J.Neurophysiol. 2003, 89:2647-2654.
75. Straiker A.J., Maguire G., Mackie K., Lindsey J. Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Investig. Ophthalmol. Vis. Sci. 1999, 40:2442-2448.
76. van der Stelt M., Di Marzo V. Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med. 2005, 7:37-50.
77. Walsh S., Gorman A.M., Finn D.P., Dowd E. The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats. Brain Res. 2010, 1363:40-48.
78. Yazulla S. Endocannabinoids in the retina: from marijuana to neuroprotection. Prog. Retin Eye Res. 2008, 27:501-526.
79. Yazulla S., Studholme K.M., McIntosh H.H., Deutsch D.G. Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. J.Comp. Neurol. 1999, 415:80-90.
80. Yazulla S., Studholme K.M., McIntosh H.H., Fan S.F. Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings. Vis. Neurosci. 2000, 17:391-401.
81. Zogopoulos P., Vasileiou I., Patsouris E., Theocharis S. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects. J.Appl. Toxicol. 2013, 33:246-264.